GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Database Last Updated
ChEBI February 3, 2022
KEGG February 3, 2022
LIPID MAPS Structure Database February 3, 2022
LipidBank February 3, 2022
PubChem February 3, 2022
Main Class Sub Class LM ID Common Name Systematic Name LipidBank ID KEGG ID ▲ PubChem CID ChEBI ID Exact Mass Formula
Acidic glycosphingolipids
Gangliosides
NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
1735.960787
C81H145N3O36
Acidic glycosphingolipids
Gangliosides
NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
1763.992087
C83H149N3O36
Acidic glycosphingolipids
Gangliosides
NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
1792.023387
C85H153N3O36
Acidic glycosphingolipids
Gangliosides
NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
1820.054687
C87H157N3O36
Acidic glycosphingolipids
Gangliosides
NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
1790.007737
C85H151N3O36
Acidic glycosphingolipids
Gangliosides
NeuAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
1818.039037
C87H155N3O36
Acidic glycosphingolipids
Gangliosides
NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer
Acidic glycosphingolipids
Gangliosides
NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
2086.056935
C93H163N5O46
Acidic glycosphingolipids
Gangliosides
NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
2114.088235
C95H167N5O46
Acidic glycosphingolipids
Gangliosides
NeuAcalpha2-3(GalNAcbeta1-4)Galbeta1-4GlcNAcbeta1-6(GalNAcbeta1-3Galalpha1-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
2142.119535
C97H171N5O46
Displaying entries 5961 - 5970 of 6008 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01